Pediatric Multicenter Study of REPEL-CV

SyntheMed

Status and phase: Unknown; Phase 2

Conditions: Adhesions

Treatments: Device: REPEL-CV

Study type: Interventional

Funder types: Industry

Identifiers

NCT00116233

LMS0104RCV

Details and patient eligibility

About

This trial will study REPEL-CV for reducing post operative adhesions following cardiovascular (cv) surgery.

Full description

• Efficacy at second sternotomy

Sex: All

Ages: 1 day to 1 year old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Stage sternotomies

Exclusion criteria

• Delayed closure beyond 5 days

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind